Michael T. Yin - Concepedia

Author

Michael T. Yin

Columbia University ORCID

Also Known As

Bares, S.H., Bernath, Hannah, M. T. Yin, M. Yin, M.T. YIN, M.T. Yin, MICHAEL YIN, MT Yin, Mack, Wendy J., Maoxu Yin

317

Publications

13.5K

Citations

H-Index

145

Concepts

All Affiliations

Columbia University Columbia University Irving Medical Center University of California, San Francisco Aaron Diamond AIDS Research Center San Francisco VA Medical Center

About

Michael T. Yin is an author at Columbia University specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	39	5.8K
2	Health Sciences	4	4	352
3	Nursing	4	4	72
4	Engineering	2	2	102
5	Education	1	1	21

Michael T. Yin

141

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike Lihong Liu, Pengfei Wang, Manoj S. Nair, Nature VaccinationVaccine TargetMultiple EpitopesImmunologyAntibody Engineering	2020	1.6K
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 Lihong Liu, Sho Iketani, Yicheng Guo, Nature Antibody EvasionImmunologyVirologyAntibody EngineeringViral Structural Protein	2021	1.4K
Antibody evasion properties of SARS-CoV-2 Omicron sublineages Sho Iketani, Lihong Liu, Yicheng Guo, Nature	2022	848
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 Qian Wang, Yicheng Guo, Sho Iketani, Nature	2022	819
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials Paul E. Sax, David A. Wohl, Michael T. Yin, The Lancet Treatment And PreventionMedicineAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2015	593
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans Julie A. Womack, Joseph L. Goulet, Cynthia L. Gibert, PLoS ONE	2011	260
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 Pengfei Wang, Manoj S. Nair, Lihong Liu, Nature Antibody ResistanceImmunologyVirologyHumoral ImmunityViral Structural Protein	2021	255
Bone structure and turnover in type 2 diabetes mellitus Aimee Shu, Michael T. Yin, Emily M. Stein, Osteoporosis International Body CompositionPhysiologyDiabetesType 2Osteoarthritis	2011	202
Recommendations for Evaluation and Management of Bone Disease in HIV Todd T. Brown, Jennifer Hoy, Marco Borderi, Clinical Infectious Diseases	2015	178
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization David D. Ho, Pengfei Wang, Lihong Liu,	2021	169

Page 1